There was no question for Eilish that she wanted to use what happened to Aoife as a positive driving force for change, and so ...

Small fragments, big impact: discovering the 'shearosomes' that drive cancer's spreadA collaborative study reveals an unexpected way cancer spreads through the body – by shedding tiny, previously ...

Turning cancer’s weakness into a weapon: 20 years of PARP inhibitors and BRCA researchTwo decades ago, a pivotal exchange between two scientists sparked a scientific and medical revolution. Professor ...

Thousands of women with breast cancer could be spared unnecessary treatment, thanks to a simple test which can identify whether or not their cancer is likely to return – just two weeks after starting ...

Late-effects of paediatric cancer treatmentNote: the ICR’s standard minimum entry requirement is a relevant undergraduate Honours degree (First or 2:1). Master in Epidemiology, Public Health, Data ...

PI3K inhibitors: decades of partnership between ICR researchers and industry leads to a new class of cancer drugs We share the story of a pioneering and collaborative research programme at the ICR, ...

A promising new therapy can help patients with aggressive advanced breast cancer live longer and delay the need for further chemotherapy, new research has shown. The international study, funded by ...

Accelerating progress in drug development for the childhood brain cancer diffuse midline gliomaDiffuse midline gliomas (DMGs) are one of the most aggressive and hard-to-treat childhood cancers. These ...

Scientists from The Institute of Cancer Research, London, will be part of a team of international researchers who have secured funding to study the genetic secrets of childhood cancer neuroblastoma.

A recent study on an aggressive type of brain cancer has significantly advanced the understanding of the spectrum of tumours that occur in teenagers and young adults (TYA).

Blood cancer is an umbrella term for cancers affecting the blood, bone marrow or lymphatic system.

A spit test, where a sample can be collected at home, is more accurate at identifying future risk of prostate cancer for some men than the current standard PSA blood test, a new study reports. Results ...